Home/ Supplements/ Omega 3/ Fish Oil 1000 mg

Fish Oil 1000 mg

product on market Softgel Capsule AvPAK Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 40% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Fish oil provides omega-3 fatty acids, which have strong evidence for supporting cardiovascular health. Vitamin E acts as an antioxidant to protect these fats from oxidation. Due to the very low evidence coverage of 0.4%, the specific formulation's overall efficacy remains limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Fish Oil 1000 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Softgel Capsule(s)
Serving Size
50
Servings
Fat/Fatty Acid
Product Type
40%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 Calorie(s)
Calories from Fat
10 Calorie(s)
Total Fat
1 Gram(s) (2% DV)
3 IU (10% DV)
Within RDA (0.1× RDA) 179 studies (A:3, B:90)
1000 mg
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

Gelatin Glycerin purified Water
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Warnings & Precautions

Contains Fish (sardine, mackerel, anchovy).

Additional Information

NDC 50268-308-15 50 Softgels (5 x 10) Unit Dose

Questions or Comments call 1-855-361-3993

Metadata

Product Details

UPC / SKU5026830815
DSLD Entry Date2022-08-23
Product TypeFat/Fatty Acid
FormSoftgel Capsule
BrandAvPAK
DSLD ID271327
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.